Finance

Lists
Why is ALLO down 2,60%?
Dive Deeper
ALLO:NASDAQ
Allogene Therapeutics Inc
1,50ย $
-2,60%
(-0,040) 1D
1,48ย $
-1,33% (-0,020)
Pre-market
Closed: 2 ีฐีธีฏ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALLO...
Open
1,57ย $
High
1,58ย $
Low
1,50ย $
Mkt. cap
518,24ย ีดีฌีถ
Avg. vol.
5,48ย ีดีฌีถ
Volume
7,16ย ีฐีฆึ€
52-wk high
4,46ย $
52-wk low
1,04ย $
EPS
-0,67ย $
Beta
0,56
Shares outstanding
345,49ย ีดีฌีถ
No. of employees
150
Open
1,57ย $
High
1,58ย $
Low
1,50ย $
Mkt. cap
518,24ย ีดีฌีถ
Avg. vol.
5,48ย ีดีฌีถ
Volume
7,16ย ีฐีฆึ€
52-wk high
4,46ย $
52-wk low
1,04ย $
EPS
-0,67ย $
Beta
0,56
Shares outstanding
345,49ย ีดีฌีถ
No. of employees
150
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
6 ึ€ีธีบีฅ ีกีผีกีป
Can Vanda Pharmaceuticals (NASDAQ:VNDA) Afford To Invest In Growth?
Columbus Ledger-Enquirer
Columbus Ledger-Enquirer
·
13 ึ€ีธีบีฅ ีกีผีกีป
Wall St futures dip as tech stocks take a breather
Yahoo Finance
Yahoo Finance
·
1 ีชีกีด ีกีผีกีป
Should You Invest in the First Trust NASDAQ Bank ETF (FTXO)?
About Allogene Therapeutics Inc
CEO-
Employees150
Founded2017
HeadquartersSouth San Francisco, ิฟีกีฌีซึ†ีธีผีถีซีก, ี„ีซีกึีตีกีฌ ี†ีกีฐีกีถีฃีถีฅึ€
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to ALLO in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ALLO in the last 3 months.
Highest
Current 1,50ย $
14,00ย $ (+833,33%)
Average
10,25ย $ (+583,33%)
Lowest
8,00ย $ (+433,33%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Maintained
14,00ย $
+833,3%
09/30/2026
Brian Cheng
J.P. Morgan
Hold
Maintained
-
-
08/17/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/12/2026
Unknown Analyst
UBS
Buy
Reiterated
8,00ย $
+433,3%
08/13/2026
Luca Issi
RBC Capital
Buy
Reiterated
9,00ย $
+500%
08/12/2026
Biren Amin
Piper Sandler
Buy
Maintained
10,00ย $
+566,7%
08/13/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/13/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
7,00ย $
+366,7%
05/14/2026
Roger Song
Jefferies
Buy
Maintained
10,00ย $
+566,7%
04/15/2026
Jack Allen
Robert W. Baird
Buy
Maintained
9,00ย $
+500%
04/14/2026
William Pickering
Bernstein
Hold
Maintained
3,85ย $
+156,7%
04/14/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
11,00ย $
+633,3%
04/16/2026
Reni Benjamin
Citizens JMP
Buy
Maintained
8,00ย $
+433,3%
04/14/2026
Samantha Semenkow
Citi
Buy
Reiterated
4,00ย $
+166,7%
04/09/2026
Asthika Goonewardene
Truist Financial
Buy
Maintained
10,00ย $
+566,7%
03/13/2026
Last report
12 ึ…ีฃีฝ, 2026 ีฉ.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,13ย $ / -0,15ย $
+12,16%beat
Revenue / Est. (USD)
4,64ย ีดีฌีถ / 2,22ย ีฐีฆึ€
+208ย 909,01%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ีฉ. ีฝีฅีบ
2025 ีฉ. ีคีฅีฏ
2026 ีฉ. ีดึ€ีฟ
2026 ีฉ. ีฐีถีฝ
Revenue
-
-
-
4,64ย ีดีฌีถ
Cost of goods sold
31,16ย ีดีฌีถ
28,63ย ีดีฌีถ
32,00ย ีดีฌีถ
30,72ย ีดีฌีถ
Cost of revenue
31,16ย ีดีฌีถ
28,63ย ีดีฌีถ
32,00ย ีดีฌีถ
30,72ย ีดีฌีถ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,74ย ีดีฌีถ
13,77ย ีดีฌีถ
14,09ย ีดีฌีถ
20,84ย ีดีฌีถ
Operating expense
13,74ย ีดีฌีถ
13,77ย ีดีฌีถ
14,09ย ีดีฌีถ
20,84ย ีดีฌีถ
Total operating expenses
44,90ย ีดีฌีถ
42,40ย ีดีฌีถ
46,09ย ีดีฌีถ
51,56ย ีดีฌีถ
Operating income
-44,90ย ีดีฌีถ
-42,40ย ีดีฌีถ
-46,09ย ีดีฌีถ
-46,92ย ีดีฌีถ
Other non operating income
-81,00ย ีฐีฆึ€
247,00ย ีฐีฆึ€
212,00ย ีฐีฆึ€
-61,00ย ีฐีฆึ€
EBT including unusual items
-41,40ย ีดีฌีถ
-38,81ย ีดีฌีถ
-42,61ย ีดีฌีถ
-42,68ย ีดีฌีถ
EBT excluding unusual items
-41,40ย ีดีฌีถ
-38,81ย ีดีฌีถ
-42,61ย ีดีฌีถ
-42,68ย ีดีฌีถ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-41,40ย ีดีฌีถ
-38,81ย ีดีฌีถ
-42,61ย ีดีฌีถ
-42,68ย ีดีฌีถ
Net profit margin
-
-
-
-919,76%
Earnings per share
-0,19
-0,17
-0,18
-0,13
Interest and investment income
3,93ย ีดีฌีถ
3,66ย ีดีฌีถ
3,57ย ีดีฌีถ
4,65ย ีดีฌีถ
Interest expense
-344,00ย ีฐีฆึ€
-313,00ย ีฐีฆึ€
-300,00ย ีฐีฆึ€
-343,00ย ีฐีฆึ€
Net interest expenses
3,58ย ีดีฌีถ
3,35ย ีดีฌีถ
3,27ย ีดีฌีถ
4,30ย ีดีฌีถ
Depreciation and amortization charges
-
-
-
-
EBITDA
-41,80ย ีดีฌีถ
-39,35ย ีดีฌีถ
-43,22ย ีดีฌีถ
-44,28ย ีดีฌีถ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps